"Silly walks" in Parkinson's disease: unusual presentation of dopaminergic-induced dyskinesias.
作者信息
Růžička Evžen, Zárubová Kateřina, Nutt John G, Bloem Bastiaan R
出版信息
Mov Disord. 2011 Aug 1;26(9):1782-4. doi: 10.1002/mds.23667. Epub 2011 Apr 14.
Abstract
摘要
相似文献
1
"Silly walks" in Parkinson's disease: unusual presentation of dopaminergic-induced dyskinesias.
Mov Disord. 2011 Aug 1;26(9):1782-4. doi: 10.1002/mds.23667. Epub 2011 Apr 14.
2
The role of glutamatergic transmission in the pathogenesis of levodopa-induced dyskinesias. Potential therapeutic approaches.
Neurol Neurochir Pol. 2001;35 Suppl 3:65-8.
3
Lees' syndrome: a case series.
Arq Neuropsiquiatr. 2011 Oct;69(5):756-9. doi: 10.1590/s0004-282x2011000600006.
4
Peak-dose dyskinesia; an acceptable price for mobility in late-stage Parkinson's disease?
Clin Neurophysiol. 2005 Sep;116(9):1997-8. doi: 10.1016/j.clinph.2005.06.009.
5
Therapies for dopaminergic-induced dyskinesias in Parkinson disease.
Ann Neurol. 2011 Oct;70(4):667; author reply 667-8. doi: 10.1002/ana.22604.
6
Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment.
Postgrad Med J. 2007 Jun;83(980):384-8. doi: 10.1136/pgmj.2006.054759.
7
Rating scales for dyskinesias in Parkinson's disease.
Mov Disord. 1999;14 Suppl 1:48-53.
8
Ropinirole monotherapy induced severe reversible dyskinesias in Parkinson's disease.
Mov Disord. 2013 Jul;28(8):1159-60. doi: 10.1002/mds.25318. Epub 2013 Feb 5.
9
Serotonergic involvement in levodopa-induced dyskinesias in Parkinson's disease.
J Clin Neurosci. 2012 Mar;19(3):343-8. doi: 10.1016/j.jocn.2011.09.008. Epub 2012 Jan 16.
10
L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach.
Mov Disord. 1999;14 Suppl 1:19-32.
引用本文的文献
1
Unveiling the Unpredictable in Parkinson's Disease: Sensor-Based Monitoring of Dyskinesias and Freezing of Gait in Daily Life.
Bioengineering (Basel). 2024 Apr 29;11(5):440. doi: 10.3390/bioengineering11050440.
2
[Additional functional symptoms in Parkinson's disease and tremor syndromes].
Nervenarzt. 2024 Jun;95(6):525-531. doi: 10.1007/s00115-023-01594-1. Epub 2024 Jan 5.
3
A video-atlas of levodopa-induced dyskinesia in Parkinson's disease: terminology matters.
Neurol Sci. 2024 Apr;45(4):1389-1397. doi: 10.1007/s10072-023-07209-6. Epub 2023 Nov 21.
4
Adapting STN-DBS Stimulation Pattern for the Treatment of "Choreo Dystonic Lower Limb Dyskinesia" in Parkinson's Disease.
Mov Disord Clin Pract. 2022 Nov 11;10(2):323-325. doi: 10.1002/mdc3.13607. eCollection 2023 Feb.
5
Clinical neurophysiology of Parkinson's disease and parkinsonism.
Clin Neurophysiol Pract. 2022 Jun 30;7:201-227. doi: 10.1016/j.cnp.2022.06.002. eCollection 2022.
6
Pearls & Oy-sters: Marionette Walk in Parkinson Disease: A Rare Dyskinetic-Dystonic Gait Pattern Complication Improved by Visual Cueing.
Neurology. 2022 Jul 11;99(2):77-81. doi: 10.1212/WNL.0000000000200714.
7
Reply to Comment on: Successful Treatment of Levodopa/Carbidopa Intestinal Gel Associated "Biphasic-Like" Dyskinesia with Pallidal Deep Brain Stimulation.
Mov Disord Clin Pract. 2021 Apr 26;8(5):814-815. doi: 10.1002/mdc3.13221. eCollection 2021 Jul.
8
Functional Dyskinesias following Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: A Report of Three Cases.
Mov Disord Clin Pract. 2020 Dec 2;8(1):114-117. doi: 10.1002/mdc3.13111. eCollection 2021 Jan.
9
Functional gait disorders: A sign-based approach.
Neurology. 2020 Jun 16;94(24):1093-1099. doi: 10.1212/WNL.0000000000009649. Epub 2020 Jun 1.
10
Levodopa-induced dyskinesia: clinical features, incidence, and risk factors.
J Neural Transm (Vienna). 2018 Aug;125(8):1109-1117. doi: 10.1007/s00702-018-1900-6. Epub 2018 Jul 3.
本文引用的文献
1
Psychogenic parkinsonism: a combination of clinical, electrophysiological, and [(123)I]-FP-CIT SPECT scan explorations improves diagnostic accuracy.
Mov Disord. 2006 Mar;21(3):310-7. doi: 10.1002/mds.20720.
2
A video review of the diagnosis of psychogenic gait: appendix and commentary.
Mov Disord. 1999 Nov;14(6):914-21. doi: 10.1002/1531-8257(199911)14:6<914::aid-mds1002>3.0.co;2-b.
3
Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
Mov Disord. 1994 Jan;9(1):2-12. doi: 10.1002/mds.870090103.
4
Do parkinsonian symptoms and levodopa-induced dyskinesias start in the foot?
Neurology. 1994 Sep;44(9):1613-6. doi: 10.1212/wnl.44.9.1613.
5
Young onset Parkinson's disease.
Mov Disord. 1987;2(2):73-91. doi: 10.1002/mds.870020201.
6
Onset and end-of-dose levodopa-induced dyskinesias. Possible treatment by increasing the daily doses of levodopa.
Arch Neurol. 1978 May;35(5):261-3. doi: 10.1001/archneur.1978.00500290007002.
Zotero 插件